ResearcherCurtin UniversityNo recent work listed
Omar Elaskalani
Matched on ORCID iD 0000-0002-1299-508X; OpenAlex author ID A5085118645. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2017: 3 papers · 2018: 1 paper · 2019: none · 2020: 1 paper
Papers 5
- Antiplatelet Drug Ticagrelor Enhances Chemotherapeutic Efficacy by Targeting the Novel P2Y12-AKT Pathway in Pancreatic Cancer Cells. Co-author DOI 10.3390/cancers12010250↗
- Molecular and cellular mechanisms of chemoresistance in pancreatic cancer. First author DOI 10.1016/j.jbior.2017.11.007↗
- The Role of Platelet-Derived ADP and ATP in Promoting Pancreatic Cancer Cell Survival and Gemcitabine Resistance. Co-author DOI 10.3390/cancers9100142↗
- Pancreatic Cancer-Induced Neutrophil Extracellular Traps: A Potential Contributor to Cancer-Associated Thrombosis. First author DOI 10.3390/ijms18030487↗
- Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer. Co-author DOI 10.4251/wjgo.v9.i1.37↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Pat Metharom · 5 shared papers, 2017–2020 · strength 0.53
- Paper Antiplatelet Drug Ticagrelor Enhances Chemotherapeutic Efficacy by Targeting the Novel P2Y12-AKT Pathway in Pancreatic … DOI 10.3390/cancers12010250↗
- Paper Pancreatic Cancer-Induced Neutrophil Extracellular Traps: A Potential Contributor to Cancer-Associated Thrombosis. DOI 10.3390/ijms18030487↗
- Paper Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer. DOI 10.4251/wjgo.v9.i1.37↗
- Norbaini Binti Abdol Razak · 4 shared papers, 2017–2020 · strength 0.44
- Paper Antiplatelet Drug Ticagrelor Enhances Chemotherapeutic Efficacy by Targeting the Novel P2Y12-AKT Pathway in Pancreatic … DOI 10.3390/cancers12010250↗
- Paper Pancreatic Cancer-Induced Neutrophil Extracellular Traps: A Potential Contributor to Cancer-Associated Thrombosis. DOI 10.3390/ijms18030487↗
- Paper Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer. DOI 10.4251/wjgo.v9.i1.37↗
- Marco Falasca · 4 shared papers, 2017–2020 · strength 0.41
- Paper Antiplatelet Drug Ticagrelor Enhances Chemotherapeutic Efficacy by Targeting the Novel P2Y12-AKT Pathway in Pancreatic … DOI 10.3390/cancers12010250↗
- Paper Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer. DOI 10.4251/wjgo.v9.i1.37↗
- Paper Molecular and cellular mechanisms of chemoresistance in pancreatic cancer. DOI 10.1016/j.jbior.2017.11.007↗
- Alice Domenichini · 1 shared paper, 2020 · strength 0.13
- Aikaterini Emmanouilidi · 1 shared paper, 2018 · strength 0.09
- Aleksandra Adamska · 1 shared paper, 2018 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.